Tjeerd S. Aukema

Haga Hospital

Papers

5

Total Citations

109

H-Index

3

About

Dr. Tjeerd S. Aukema is a leading colorectal surgeon whose research is transforming surgical outcomes for rectal cancer patients. His work centers on two critical areas: preventing life-threatening complications and optimizing surgical techniques to preserve quality of life. Dr. Aukema’s landmark contribution is the AVOID trial (2024, 84 citations), a multicentre, randomised, phase 3 study demonstrating that indocyanine green near-infrared fluorescence imaging can significantly reduce anastomotic leakage in minimally invasive colorectal surgery—a practice-changing finding that directly improves patient safety. He has also advanced the evidence base for total mesorectal excision (TME), authoring a comprehensive systematic review and meta-analysis (2024, 16 citations) comparing open, laparoscopic, robot-assisted, and transanal approaches, revealing critical insights into functional outcomes and quality of life. As a key figure in the EUREKA collaborative, Dr. Aukema is leading a multinational cohort study evaluating robotic rectal cancer surgery, and has developed predictive models for positive circumferential resection margins (2025). His work, consistently published in high-impact journals, is defining the future of precision, patient-centered colorectal surgery.

Research Focus

Key Achievements

3
H-Index
5
Papers
109
Total Citations
22
Avg Citations/Paper
🏆 Most Cited Paper
Indocyanine green near-infrared fluorescence bowel perfusion assessment to prevent anastomotic leakage in minimally invasive colorectal surgery (AVOID): a multicentre, randomised, controlled, phase 3 trial
84 citations · 2024
📈 Most Prolific Year: 2024 (4 Papers)
🤝 Key Collaborators: 109
🏛 Institutions: Haga Hospital

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago